Primecap Management Co. CA Has $410.78 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Primecap Management Co. CA grew its holdings in CME Group Inc. (NASDAQ:CME) by 3.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,861,690 shares of the financial services provider’s stock after buying an additional 58,647 shares during the quarter. Primecap Management Co. CA’s holdings in CME Group were worth $410,782,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Harbor Capital Advisors Inc. increased its stake in shares of CME Group by 0.6% in the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after buying an additional 45 shares in the last quarter. CVA Family Office LLC increased its stake in shares of CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after buying an additional 46 shares in the last quarter. Lester Murray Antman dba SimplyRich boosted its holdings in CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after acquiring an additional 50 shares during the last quarter. Zions Bancorporation N.A. boosted its holdings in CME Group by 3.7% in the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after acquiring an additional 54 shares during the last quarter. Finally, Quent Capital LLC boosted its holdings in CME Group by 10.2% in the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 12.01 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,621 shares of company stock valued at $3,441,063. Company insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME stock opened at $228.00 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.74. The company has a market cap of $82.16 billion, a P/E ratio of 23.97, a P/E/G ratio of 5.30 and a beta of 0.55. The business has a fifty day simple moving average of $223.21 and a 200 day simple moving average of $210.81.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the firm earned $2.25 EPS. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. On average, sell-side analysts forecast that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. CME Group’s payout ratio is presently 48.37%.

Analyst Ratings Changes

Several research firms recently issued reports on CME. Piper Sandler raised their price target on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. TD Cowen began coverage on CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target on the stock. in a report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their target price on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Finally, Keefe, Bruyette & Woods raised their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $224.47.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.